Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza) in the Management of Clinically Significant Dry Eye
Latest Information Update: 19 Mar 2024
At a glance
- Drugs Dexamethasone (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 08 Jun 2023 Status changed from active, no longer recruiting to discontinued.
- 27 Feb 2023 Planned primary completion date changed from 1 Feb 2023 to 1 Mar 2023.
- 03 Jan 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Feb 2023.